UCB (WBO:UCB) Other Operating Expense : €-542 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is UCB Other Operating Expense?

UCB's Other Operating Expense for the six months ended in Dec. 2023 was €-227 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-542 Mil.

UCB's quarterly Other Operating Expense declined from Dec. 2022 (€-129 Mil) to Jun. 2023 (€-315 Mil) but then increased from Jun. 2023 (€-315 Mil) to Dec. 2023 (€-227 Mil).

UCB's annual Other Operating Expense declined from Dec. 2021 (€-166 Mil) to Dec. 2022 (€-243 Mil) and declined from Dec. 2022 (€-243 Mil) to Dec. 2023 (€-542 Mil).

UCB Other Operating Expense Historical Data

The historical data trend for UCB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UCB Other Operating Expense Chart

UCB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

14.00

-42.00

-166.00

-243.00

-542.00

UCB Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															-99.00	-114.00	-129.00	-315.00	-227.00

UCB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-542 Mil.

UCB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of UCB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

UCB (WBO:UCB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » UCB SA (WBO:UCB) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

UCBJY:USA UCBJF:USA UCBb:UK 0NZT:UK UNC:Germany UCB:Belgium

Address

Allee de la Recherche, 60, Brussels, BEL, B-1070

Website

https://www.ucb.com

UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key products are Cimzia (immunology), Vimpat (epilepsy), Neupro (Parkinson's disease and restless leg syndrome), Briviact (epilepsy), Bimzelx (psoriasis), Evenity (osteoporosis), Nayzilam (cluster seizures), and Fintepla (Dravet Syndrome and Lennox-Gastaut Syndrome).

UCB (WBO:UCB) Headlines

No Headlines